Tibolone vs placebo
Cerebrovascular event (all doses) · postmenopausal women with or without vasomotor symptoms
It is very uncertain whether tibolone changes cerebrovascular events (all doses) compared with placebo (very low certainty).
1 finding from 1 review
- Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes onlyOR 1.74 [0.99, 3.04]4 studies · 7930 participantsVery low